On July 26, Gelon Hui announced that Nawei Technology (688690.SH) released its performance forecast for the first half of 2024, and is expected to achieve revenue of approximately RMB 0.34 billion in the first half of 2024, an increase of approximately 15.12% year-on-year. It is expected to achieve a net profit attributable to the owner of the parent company of approximately RMB 45.0406 million in the first half of 2024, an increase of approximately 41.51% year-on-year. It is expected to achieve a net profit attributable to the owner of the parent company after deducting non-recurring gains and losses of approximately RMB 36.5238 million in the first half of 2024, an increase of approximately 88.83% year-on-year.
In the first half of 2024, the company's comprehensive gross margin is approximately 72.40%, which is lower due to the increased proportion of instrument product revenue. The company continues to introduce high-end technical talents to improve its innovative capabilities, layout product research and development plans for key and major needs, benchmarking international leading manufacturers to build long-term competitive advantages. The R&D investment in the first half of 2024 is approximately RMB 77.08 million, accounting for approximately 22.68% of revenue. Innovative products such as nucleic acid synthesis carrier microspheres and new generation affinity chromatography medium NMab Titan were released and launched in the first half of the year.